Correlates of receiving recommended adolescent vaccines among adolescent females in North Carolina.
BACKGROUND
Immunization is a successful and cost-effective method for preventing disease, yet many adolescents do not receive recommended vaccines. We assessed correlates of uptake of three vaccines (tetanus booster, meningococcal, and human papillomavirus [HPV] vaccines) recommended for adolescent females. Methods. We examined cross-sectional data from 647 parents of 11-20 year-old females from North Carolina who completed the Carolina HPV Immunization Measurement and Evaluation (CHIME) Project follow-up survey in late 2008. Analyses used ordinal and binary logistic regression.


RESULTS
Only 17% of parents indicated their daughters had received all three vaccines. Eighty-seven percent of parents indicated their daughters had received tetanus booster vaccine, 36% reported vaccination against meningococcal disease, and 36% reported HPV vaccine initiation. Daughters aged 13-15 years (OR = 1.70, 95% CI: 1.09-2.64) or 16-20 years (OR = 2.28, 95% CI: 1.51-3.44) had received a greater number of these vaccines compared to daughters aged 11-12 years. Daughters who had preventive care visits in the last year (OR = 4.81, 95% CI: 3.14-7.34) or whose parents had at least some college education (OR = 1.90, 95% CI: 1.29-2.80) had also received a greater number of these vaccines.


CONCLUSIONS
Few daughters, particularly 11-12 years olds, had received all three vaccines recommended for adolescent females. Ensuring annual preventive care visits and increasing concomitant administration of adolescent vaccines may help increase vaccine coverage.
UNC Gillings School of Global Public Health, Chapel Hill, NC, USA. preiter@email.unc.edu
Paul L
PL
Reiter
Annie-Laurie
AL
McRee
Sami L
SL
Gottlieb
Noel T
NT
Brewer
D000293:Adolescent; D000328:Adult; D002648:Child; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D022401:Meningococcal Vaccines / Q000008:administration & dosage* / Q000276:immunology*; D008875:Middle Aged; D009657:North Carolina; D053918:Papillomavirus Vaccines / Q000008:administration & dosage* / Q000276:immunology*; D013745:Tetanus Toxoid / Q000008:administration & dosage* / Q000276:immunology*; D014611:Vaccination / Q000706:statistics & numerical data*; D055815:Young Adult
D022401:Meningococcal Vaccines; D053918:Papillomavirus Vaccines; D013745:Tetanus Toxoid
J Adolesc Health. 2007 Aug;41(2):109-18
17659213
J Adolesc Health. 2009 Nov;45(5):430-7
19837348
J Womens Health (Larchmt). 2009 Oct;18(10):1679-86
19785564
Cochrane Database Syst Rev. 2005 Jul 20;(3):CD003941
16034918
Pediatrics. 2008 Oct;122(4):711-7
18829792
MMWR Morb Mortal Wkly Rep. 2009 Sep 18;58(36):997-1001
19763075
J Infect Dis. 2009 Oct 1;200(7):1059-67
19719390
Pediatrics. 2007 Oct;120(4):e783-7
17908736
Sex Transm Dis. 2011 Mar;38(3):197-204
20838362
Cancer. 2008 Nov 15;113(10 Suppl):3036-46
18980286
MMWR Recomm Rep. 2006 Mar 24;55(RR-3):1-34
16557217
Perspect Sex Reprod Health. 2004 Jan-Feb;36(1):6-10
14982671
J Adolesc Health. 2009 Nov;45(5):453-62
19837351
MMWR Recomm Rep. 2007 Mar 23;56(RR-2):1-24
17380109
Arch Pediatr Adolesc Med. 1999 Dec;153(12):1289-91
10591308
Am J Public Health. 2009 Jun;99(6):1137-42
19372507
Am J Prev Med. 2006 Jul;31(1):52-61
16777543
Pediatrics. 2003 Nov;112(5):1076-82
14595049
Arch Pediatr Adolesc Med. 1995 Aug;149(8):845-9
7633536
Am J Prev Med. 2000 Jan;18(1 Suppl):97-140
10806982
Clin Pediatr (Phila). 2006 Nov;45(9):785-94
17041165
J Adolesc Health. 1997 Sep;21(3):203-14
9283943
J Adolesc Health. 2009 Nov;45(5):445-52
19837350
Pediatr Infect Dis J. 2007 May;26(5):371-6
17468644
Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):363-72
19190161
J Adolesc Health. 2007 May;40(5):398-404
17448396
Arch Fam Med. 1994 Jul;3(7):610-3
7921297
Soc Sci Med. 2009 Aug;69(3):475-80
19540642
MMWR Recomm Rep. 2005 May 27;54(RR-7):1-21
15917737